Improving cancer care at the end of life

The Lancet Oncology
L McCahillR Virani

Abstract

Excellent care for cancer patients and their families should extend throughout the illness, and should include care provided at the end of life. Recent evidence, including a report from the Institute of Medicine, has emphasised that major reform is needed to improve relief of pain, other symptoms, and psychosocial care. This paper reviews the critical necessity for reform in end-of-life care for the field of oncology and the major educational efforts required to ensure that oncology professionals can respond to this need.

References

Dec 15, 1983·The New England Journal of Medicine·R BayerR Veatch
Nov 22, 1995·JAMA : the Journal of the American Medical Association·B Lo
Jun 26, 1995·Archives of Internal Medicine·T P Hill
Jul 18, 1996·The New England Journal of Medicine·J Lynn
Jan 2, 1997·The New England Journal of Medicine·K M Foley
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sep 8, 1998·The American Journal of Hospice & Palliative Care·T MoritaS Chihara
Jan 23, 1999·JAMA : the Journal of the American Medical Association·P A SingerM Kelner
Jul 1, 1999·Journal of Pain and Symptom Management·G MorassoF Henriquet
Jul 1, 1999·Journal of Pain and Symptom Management·M A WeitznerP B Jacobsen
Sep 4, 1999·Palliative Medicine·C PeruselliI J Higginson
Sep 25, 1999·Academic Medicine : Journal of the Association of American Medical Colleges·D E WeissmanH B Wheeler
Jan 8, 2000·Nursing Outlook·B R FerrellR Virani
Feb 3, 2000·The New England Journal of Medicine·J WolfeJ C Weeks
Feb 22, 2000·JAMA : the Journal of the American Medical Association·M W RabowS J McPhee
May 16, 2000·Journal of the American Geriatrics Society·E P McCarthyJ Lynn
Jul 6, 2000·The New England Journal of Medicine·D E Deremo, J B Fahner
Jul 21, 2001·Health Affairs·C HoganJ Lynn
Mar 12, 2002·The American Journal of Hospice & Palliative Care·B R Ferrell, R Virani
Apr 30, 2005·Journal of Palliative Medicine·B R FerrellM Grant

❮ Previous
Next ❯

Citations

Mar 21, 2002·The Lancet Oncology·J Abel
Oct 2, 2002·Journal of Vascular and Interventional Radiology : JVIR·Douglas E RamseyJean-Francois H Geschwind
Dec 27, 2005·Journal of the American College of Surgeons·W Y LauThomas W T Leung
Aug 20, 2004·Internal Medicine Journal·J R Hardy, R Vora
Oct 11, 2008·Contemporary Nurse·Christina Searle, Fran McInerney
Oct 27, 2006·Clinical Journal of Oncology Nursing·Andria P Caton, Paula Klemm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Oncology Nursing
R PolomanoA Wurster
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
Cindy L Munro, Richard H Savel
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P StoneJ R Hardy
BMJ : British Medical Journal
June Jones, Derek Willis
© 2022 Meta ULC. All rights reserved